189 related articles for article (PubMed ID: 26980106)
1. CAG repeat size in Huntingtin alleles is associated with cancer prognosis.
Thion MS; Tézenas du Montcel S; Golmard JL; Vacher S; Barjhoux L; Sornin V; Cazeneuve C; Bièche I; Sinilnikova O; Stoppa-Lyonnet D; Durr A; Humbert S
Eur J Hum Genet; 2016 Aug; 24(9):1310-5. PubMed ID: 26980106
[TBL] [Abstract][Full Text] [Related]
2. Huntingtin gene CAG repeat size affects autism risk: Family-based and case-control association study.
Piras IS; Picinelli C; Iennaco R; Baccarin M; Castronovo P; Tomaiuolo P; Cucinotta F; Ricciardello A; Turriziani L; Nanetti L; Mariotti C; Gellera C; Lintas C; Sacco R; Zuccato C; Cattaneo E; Persico AM
Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):341-351. PubMed ID: 32652810
[TBL] [Abstract][Full Text] [Related]
3. Approaches to Sequence the HTT CAG Repeat Expansion and Quantify Repeat Length Variation.
Ciosi M; Cumming SA; Chatzi A; Larson E; Tottey W; Lomeikaite V; Hamilton G; Wheeler VC; Pinto RM; Kwak S; Morton AJ; Monckton DG
J Huntingtons Dis; 2021; 10(1):53-74. PubMed ID: 33579864
[TBL] [Abstract][Full Text] [Related]
4. A Novel Triplet-Primed PCR Assay to Detect the Full Range of Trinucleotide CAG Repeats in the Huntingtin Gene (
De Luca A; Morella A; Consoli F; Fanelli S; Thibert JR; Statt S; Latham GJ; Squitieri F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567536
[TBL] [Abstract][Full Text] [Related]
5. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
Podvin S; Reardon HT; Yin K; Mosier C; Hook V
J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
[TBL] [Abstract][Full Text] [Related]
6. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
[TBL] [Abstract][Full Text] [Related]
7. High frequency of intermediary alleles in the HTT gene in Northern Sweden - The Swedish Huntingtin Alleles and Phenotype (SHAPE) study.
Sundblom J; Niemelä V; Ghazarian M; Strand AS; Bergdahl IA; Jansson JH; Söderberg S; Stattin EL
Sci Rep; 2020 Jun; 10(1):9853. PubMed ID: 32555394
[TBL] [Abstract][Full Text] [Related]
8. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
Savitt D; Jankovic J
J Neurol Sci; 2019 Jul; 402():57-61. PubMed ID: 31103960
[TBL] [Abstract][Full Text] [Related]
9. Cancer: From Wild-Type to Mutant Huntingtin.
Thion MS; Humbert S
J Huntingtons Dis; 2018; 7(3):201-208. PubMed ID: 29889077
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.
Dagan E; Friedman E; Paperna T; Carmi N; Gershoni-Baruch R
Eur J Hum Genet; 2002 Nov; 10(11):724-8. PubMed ID: 12404104
[TBL] [Abstract][Full Text] [Related]
11. Attenuated huntingtin gene CAG nucleotide repeat size in individuals with Lynch syndrome.
Dalene Skarping K; Arning L; Petersén Å; Nguyen HP; Gebre-Medhin S
Sci Rep; 2024 Feb; 14(1):4300. PubMed ID: 38383663
[TBL] [Abstract][Full Text] [Related]
12. Biallelic mutations in huntington disease: A new case with just one affected parent, review of the literature and terminology.
Uhlmann WR; Peñaherrera MS; Robinson WP; Milunsky JM; Nicholson JM; Albin RL
Am J Med Genet A; 2015 May; 167A(5):1152-60. PubMed ID: 25736541
[TBL] [Abstract][Full Text] [Related]
13. Loss of CAA interruption and intergenerational CAG instability in Chinese patients with Huntington's disease.
Bao YF; Li XY; Dong Y; Wu ZY
J Mol Med (Berl); 2023 Jul; 101(7):869-876. PubMed ID: 37231148
[TBL] [Abstract][Full Text] [Related]
14. HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease.
Menéndez-González M; Clarimón J; Rosas-Allende I; Blázquez M; San Martín ES; García-Fernández C; Lleó A; Dols-Icardo O; Illán-Gala I; Morís G; Ribacoba R; Álvarez V; Martínez C
Neurobiol Aging; 2019 Apr; 76():215.e9-215.e14. PubMed ID: 30583877
[TBL] [Abstract][Full Text] [Related]
15. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.
Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA
Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Detection and Sizing of the HTT CAG Repeat Expansion in Huntington Disease Using an Improved Triplet-Primed PCR Assay.
Zhao M; Lee CG; Law HY; Chong SS
Neurodegener Dis; 2016; 16(5-6):348-51. PubMed ID: 27207688
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Huntington's disease gene CAG trinucleotide repeat alleles in patients with bipolar disorder.
Ramos EM; Gillis T; Mysore JS; Lee JM; Alonso I; Gusella JF; Smoller JW; Sklar P; MacDonald ME; Perlis RH
Bipolar Disord; 2015 Jun; 17(4):403-8. PubMed ID: 25726852
[TBL] [Abstract][Full Text] [Related]
18. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
Rebbeck TR; Kantoff PW; Krithivas K; Neuhausen S; Blackwood MA; Godwin AK; Daly MB; Narod SA; Garber JE; Lynch HT; Weber BL; Brown M
Am J Hum Genet; 1999 May; 64(5):1371-7. PubMed ID: 10205268
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.
da Silva IDS; Apolinário TA; de Andrade Agostinho L; Paiva CLA
J Mol Neurosci; 2022 May; 72(5):1116-1124. PubMed ID: 35275350
[TBL] [Abstract][Full Text] [Related]
20. The Danish HD Registry-a nationwide family registry of HD families in Denmark.
Gilling M; Budtz-Jørgensen E; Boonen SE; Lildballe D; Bojesen A; Hertz JM; Sørensen SA
Clin Genet; 2017 Sep; 92(3):338-341. PubMed ID: 28155235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
